These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20682059)

  • 1. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis.
    Sander M; Spies CD; Martiny V; Rosenthal C; Wernecke KD; von Heymann C
    Crit Care; 2010; 14(4):R148. PubMed ID: 20682059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
    Riddell RE; Buth KJ; Sullivan JA
    Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin versus tranexamic acid in children undergoing cardiac surgery: an observational study.
    Willems A; De Groote F; Dumoulin M; Fils JF; Van der Linden P
    Eur J Cardiothorac Surg; 2019 Oct; 56(4):688-695. PubMed ID: 30928999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children.
    Muthialu N; Balakrishnan S; Sundar R; Muralidharan S
    Ann Card Anaesth; 2015; 18(1):23-6. PubMed ID: 25566706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
    Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome.
    Koster A; Börgermann J; Zittermann A; Lueth JU; Gillis-Januszewski T; Schirmer U
    Br J Anaesth; 2013 Jan; 110(1):34-40. PubMed ID: 22986419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of antifibrinolytic medications in pediatric heart surgery.
    Pasquali SK; Li JS; He X; Jacobs ML; O'Brien SM; Hall M; Jaquiss RD; Welke KF; Peterson ED; Shah SS; Jacobs JP
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):550-7. PubMed ID: 22264414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
    Siemens K; Sangaran DP; Hunt BJ; Murdoch IA; Tibby SM
    Anesth Analg; 2022 May; 134(5):987-1001. PubMed ID: 34633994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery.
    Lin CY; Shuhaiber JH; Loyola H; Liu H; Del Nido P; DiNardo JA; Pigula FA
    PLoS One; 2015; 10(5):e0126514. PubMed ID: 25954976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies.
    Hutton B; Joseph L; Fergusson D; Mazer CD; Shapiro S; Tinmouth A
    BMJ; 2012 Sep; 345():e5798. PubMed ID: 22968722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
    Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
    Graham EM; Atz AM; Gillis J; Desantis SM; Haney AL; Deardorff RL; Uber WE; Reeves ST; McGowan FX; Bradley SM; Spinale FG
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1069-76. PubMed ID: 22075061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk associated with aprotinin in cardiac surgery.
    Mangano DT; Tudor IC; Dietzel C; ;
    N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients.
    Bernet F; Carrel T; Marbet G; Skarvan K; Stulz P
    J Card Surg; 1999; 14(2):92-7. PubMed ID: 10709819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.